GlycoMimetics Vs. Revance Therapeutics Industry Stock Comparison

Sell

47

GLYC
GlycoMimetics

Last Price:

0.32

Seasonality Move:

11.03%

Sell

9

RVNC
Revance Therapeutics

Last Price:

3.73

Seasonality Move:

6.97%

Sell

47

GlycoMimetics (GLYC) is a Sell

Is GlycoMimetics a Buy, Sell or Hold?

The current GlycoMimetics [GLYC] share price is $0.32. The Score for GLYC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
GLYC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

9

Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

The current Revance Therapeutics [RVNC] share price is $3.73. The Score for RVNC is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

GLYC Stock Price Chart

What is GlycoMimetics's stock price today?

The GlycoMimetics share price today is $0.32
The current trend is moderately bearish and GLYC is experiencing slight selling pressure.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

The Revance Therapeutics share price today is $3.73
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing selling pressure, which indicates risk of future bearish movement.

GLYC Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.03	Buy
Relative Strength Index (14 RSI):	47.47	Sell
Chaikin Money Flow:	-460494	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.24 - 0.44)	Sell
Bollinger Bands (100):	(0.14 - 0.32)	Buy

RVNC Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.45	Sell
Relative Strength Index (14 RSI):	32.99	Sell
Chaikin Money Flow:	-1111191	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(3.97 - 5.77)	Sell
Bollinger Bands (100):	(3.78 - 6.28)	Sell

GLYC Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.37	Sell
20-day SMA:	0.39	Sell
50-day SMA:	0.25	Buy
200-day SMA:	0.96	Sell
8-day EMA:	0.36	Sell
20-day EMA:	0.35	Sell
50-day EMA:	0.3	Buy
200-day EMA:	0.74	Sell

RVNC Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	3.98	Sell
20-day SMA:	4.79	Sell
50-day SMA:	5.16	Sell
200-day SMA:	4.6	Sell
8-day EMA:	3.99	Sell
20-day EMA:	4.48	Sell
50-day EMA:	4.92	Sell
200-day EMA:	6.01	Sell

GlycoMimetics Earnings Growth & GLYC Earnings Dates

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.01 per share.

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.

GlycoMimetics Technical Analysis

	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21	Nov 22
	Nov
	11	12	13	14	15	18	19	20	21	22
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Revance Therapeutics Technical Analysis

	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21	Nov 22
	Nov
	11	12	13	14	15	18	19	20	21	22
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):